Securities code: Jiangxi Sanxin Medtec Co.Ltd(300453) securities abbreviation: Jiangxi Sanxin Medtec Co.Ltd(300453) Announcement No.: 2022013 Jiangxi Sanxin Medtec Co.Ltd(300453)
Announcement on 2021 profit distribution plan
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Jiangxi Sanxin Medtec Co.Ltd(300453) (hereinafter referred to as “the company”) held the 17th meeting of the 4th board of directors and the 16th meeting of the 4th board of supervisors on March 15, 2022, deliberated and adopted the proposal on the company’s profit distribution plan in 2021. This profit distribution plan needs to be submitted to the company’s 2021 annual general meeting for deliberation and approval. The relevant information is hereby announced as follows:
1、 Details of profit distribution plan
After the audited profit of Daxin accounting firm in the current year is rmb18061747 yuan, the net profit attributable to shareholders of Daxin accounting firm in the previous year is rmb18062747 yuan, which is transferred to the public accounting firm according to the audited profit of rmb180619083 yuan, After deducting the cash dividend of 52537000 yuan (including tax) and stock dividend of 3940275000 yuan paid due to the implementation of profit distribution in 2020 during the reporting period, the total distributable profit of the company was 41678489037 yuan as of December 31, 2021.
According to the relevant provisions of the company law, the articles of association and the cash dividend proportion determined by the company in the letter of intent for listing and offering (dividends are distributed in cash, and the profit distributed in cash in each fiscal year shall not be less than 20% of the distributable profit realized in that year), The profit distribution plan for 2021 proposed by the company is: take 39402750000 shares as the base, distribute cash dividends of 1.50 yuan (including tax) to all shareholders for every 10 shares, with a total amount of 5910412500 yuan (including tax), no bonus shares and no capital reserve converted into share capital. (if there is any change between the disclosure date of the cash dividend plan and the equity registration date of the plan due to the conversion of convertible bonds into shares, share repurchase, equity incentive exercise and the listing of refinanced new shares, the distribution proportion will be adjusted according to the principle that the total distribution amount remains unchanged.)
2、 Legality, compliance and rationality of profit distribution plan
The company’s profit distribution plan for 2021 complies with the company law, the securities law, the accounting standards for business enterprises, the notice on further implementing the matters related to cash dividends of listed companies issued by the CSRC, the guidelines for the supervision of listed companies No. 3 – cash bonus of listed companies issued by the CSRC Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 2 – standardized operation of companies listed on GEM, articles of association and other relevant provisions. This profit distribution plan is put forward on the premise of ensuring the normal operation and long-term development of the company, comprehensively considering the operation and development of the company and the interests of the majority of investors, matching the actual operation and future development needs of the company, and taking into account the profit distribution plan and the long-term return plan of shareholders. The implementation of this profit distribution plan will not cause the company’s shortage of working capital or other adverse effects.
In conclusion, the profit distribution plan is reasonable and compliant.
3、 Opinions of independent directors and board of supervisors
1. Opinions of independent directors
The profit distribution plan formulated by the board of directors of the company conforms to the actual situation of the company, takes full account of the reasonable investment return to investors, is conducive to the sustainable, stable and healthy development of the company, complies with the relevant provisions of the company law and the articles of association, and does not damage the interests of shareholders. The independent directors of the company agreed to the company’s profit distribution plan for 2021 and agreed that the board of directors would submit the above plan to the general meeting of shareholders for deliberation.
2. Opinions of the board of supervisors
The profit distribution plan for 2021 formulated by the board of directors of the company takes into account the current financial situation and future fund use plan of the company, and organically combines the interests of shareholders with the long-term development of the company on the premise of complying with the relevant provisions of the company law, the articles of association and so on. The board of supervisors unanimously agreed that the board of directors would submit the above plan to the general meeting of shareholders for deliberation.
4、 Other instructions
1. Before the disclosure of this profit distribution plan, the company strictly controlled the scope of insiders in strict accordance with laws, regulations, normative documents and relevant provisions of the company’s system, performed the obligation of confidentiality and prohibition of insider trading to relevant insiders, and timely filed insiders to prevent the disclosure of insider information.
2. This profit distribution plan needs to be implemented after being deliberated and approved by the company’s 2021 annual general meeting of shareholders. There is still uncertainty. Please pay attention to the investment risks.
5、 Documents for future reference
1. Resolutions of the 17th meeting of the 4th board of directors;
2. Resolutions of the 16th meeting of the 4th board of supervisors;
3. Independent opinions of independent directors on matters related to the 17th meeting of the Fourth Board of directors of the company.
It is hereby announced
Jiangxi Sanxin Medtec Co.Ltd(300453) board of directors March 17, 2022
